MSB 7.69% $1.19 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-156

  1. 1,305 Posts.
    lightbulb Created with Sketch. 299
    @jb13qz "So what is the problem ? Are the inclusion and exclusion criteria too stringent ? Are their not enough recruitment centers ? Are people refusing to participant ? Are the doctors trying other therapies / trials ? Is there political or bureaucratic interference ?
    150 people over 5 months, with 200,000+ dead what a @!#$%$ joke !"


    And, if and when we are approved, then are those stats going to continue? 150 suitable candidates for every 200000 dying ain't so great !
    Last edited by Celestial: 14/10/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.